BioCentury
ARTICLE | Company News

Cambridge Antibody, Merck deal

November 4, 2002 8:00 AM UTC

CAT granted MRK a license to its human phage antibody libraries. MRK will use the libraries for R&D across a range of therapeutic areas. CAT will receive upfront license and technology access fees. CA...